Bridging the gap in AMR research: validation of a standardized <i>Galleria mellonella</i> model to evaluate <i>Clostridioides difficile</i> pathogenesis and treatment efficacy.

Front Pharmacol · 2026 · PMC13111367 · PMID 42051261

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although survival was numerically higher at 37 °C in our model, this difference did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Bridging the gap in AMR research: validation of a standardized &lt;i&gt;Galleria mellonella&lt;/i&gt; model to evaluate &lt;i&gt;Clostridioides difficile&lt;/i&gt; pathogenesis and treatment efficacy.

The sentences

Bridging the gap in AMR research: validation of a standardized <i>Galleria mellonella</i> model to evaluate <i>Clostridioides difficile</i> pathogenesis and treatment efficacy.